VistaGen Therapeutics, Inc.
VistaGen Therapeutics, Inc.
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4) | anxiety disorder, phobic disorder, psychiatric disorder, social phobia | Active, not recruiting | Phase 3 | 2026-05-22 | NCT06615557 | |
| A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder | anxiety disorder, phobic disorder, psychiatric disorder, social phobia | Recruiting | Phase 2 | 2026-02-05 | NCT06809179 | |
| Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-3) | anxiety disorder, phobic disorder, psychiatric disorder, social phobia | Active, not recruiting | Phase 3 | 2025-11-26 | NCT06358651 |